Skip to main content
. 2017 Feb 16;8(12):20113–20121. doi: 10.18632/oncotarget.15390

Figure 6. Proposed mechanism of action of cabozantinib in tumor bone microenvironment.

Figure 6

Cabozantinib could act at multiple levels in the bone metastatic process, targeting cancer cells, bone cells and interfering with the crosstalk between tumour and bone microenvironment through the modulation of RANKL/OPG axis.